Home | Structured Search | Drug Resource
Find: within
Malaria > Diagnosis Author: Rick M. Fairhurst, MD, PhD; Thomas E. Wellems, MD, PhD
Module updated - 2009-11-19
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Physical exam findings of malaria may include an axillary temperature >=37.5°C (>=99.5°F), splenomegaly, or pallor; and coma, seizures, jaundice, and respiratory distress are signs of severe P. falciparum malaria.
  • Rash and lymphadenopathy are uncommon in malaria.

Evidence:

  • The World Health Organization has established guidelines for the diagnosis of severe P. falciparum malaria that is life-threatening and requires immediate treatment (55).

Comments:

  • Although physical exam signs of pulmonary consolidation are uncommon in malaria, the clinical features of pneumonia (i.e., cough, dyspnea, and tachypnea) may overlap with those of malaria. During a period of high malaria transmission in The Gambia, 38% of young children (n=666) with clinically suspected pneumonia had P. falciparum parasitemia, no radiologic evidence of pneumonia, and no other cause of fever (56). In Uganda, 30% of young children (n=3671) had symptoms of both malaria and pneumonia, necessitating treatment with both antimalarials and antibiotics (57).
  • Pernicious complications of “benign” tertian malaria caused by P. vivax occur rarely and may include clinically significant hemolysis, splenic rupture, and acute respiratory distress syndrome (58; 59; 60).

FAQs
Harry Tagbor, MBChB, DrPH, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Rick M. Fairhurst, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Thomas E. Wellems, MD, PhD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.